Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
The Risk of MGUS Progression to Multiple Myeloma | NEJM Resident 360
Final Diagnosis -- Case 569
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Monoclonal gammopathy and primary care | British Columbia Medical Journal
Comparison of MGUS and multiple myeloma variants | Download Table
Monoclonal Gammopathy of Undetermined Significance | NEJM
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
How to Diagnose Monoclonal Gammopathy of Undetermined Significance – Consult QD
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Frontiers | Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? | Blood Cancer Journal
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
IgM paraprotein and anti-MAG sensory polyneuropathy associated with Waldenstrom's macroglobulinaemia and medullary carcinoma of the thyroid | BMJ Case Reports
Monoclonals - an overview | ScienceDirect Topics
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Monoclonal gammopathy of undetermined significance - Wikipedia
